Product Information
DEFERASIROX 180 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.8750 per EA under NDC 43598085230. Its NADAC has been published 53 times since Aug 20, 2025.
FDA first approved this application on Nov 20, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598085230
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
10/22/2025
Active Ingredients
DEFERASIROXApproval Type
Generic (ANDA)
FDA Application
ANDA210945FDA Approved
11/20/2019
TE Code
AB
On Market Since
6/25/2020
Pharmacological Classes
Price Statistics
The NADAC for DEFERASIROX 180 MG TABLET has been published 53 times since Aug 20, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8750 per EA |
|---|---|
| All-time high | $0.8750 (Aug 19, 2026) |
| All-time low | $0.8750 (Aug 20, 2025) |
| 52-week high | $0.8750 |
| 52-week low | $0.8750 |
| Median price | $0.8750 |
| Average price | $0.8750 |
| Largest weekly change | 0.0% (Aug 27, 2025) |
| Weeks tracked | 53 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEFERASIROX 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEFERASIROX 180 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.8750 per EA (NDC 43598085230), effective Aug 19, 2026.
How has the price of DEFERASIROX 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEFERASIROX 180 MG TABLET has held within roughly two percent of its current level. It has been tracked across 53 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for DEFERASIROX 180 MG TABLET?
Since Aug 20, 2025, the NADAC for DEFERASIROX 180 MG TABLET has ranged from a low of $0.8750 (Aug 20, 2025) to a high of $0.8750 (Aug 19, 2026), with a median of $0.8750 per EA.
Are there cheaper alternatives to DEFERASIROX 180 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEFERASIROX 180 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DEFERASIROX 180 MG TABLET?
DEFERASIROX 180 MG TABLET (NDC 43598085230) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.